Pemigatinib, an FGFR inhibitor, overcomes resistance to KRASG12C inhibitors in mesenchymal-like NSCLC tumors

被引：0
|
作者：
Favata, Margaret
Weber, Michael
Abdollahi, Angela
Roman, Valerie Dostalik
Farren, Matt
Gilmartin, Aidan
Kim, Sunkyu
Wee, Susan
Rios-Doria, Jonathan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
430
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Detection of KRAS amplification on extrachromosomal DNA (ecDNA) upon acquired resistance to KRASG12C inhibitors
    Hansen, Ryan J.
    Horton, Steven
    Wiese, Julie
    Bibay, BellJohn
    Mora-Blanco, E. Lorena
    Nguyen, Nam-Phuong
    Engstrom, Lars D.
    Briere, David M.
    Calinisan, Andres
    Olson, Peter
    Awad, Mark M.
    Aguirre, Andrew J.
    Christiansen, Jason
    Hassig, Christian
    Kasibhatla, Shailaja
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [42] Probing and overcoming KRASG12C inhibitor resistance by combination with a pan-KRAS SOS1 inhibitor
    Hofmann, Marco H.
    Jurado, Sabine
    Gerlach, Daniel
    Koga, Takamasa
    Trapani, Francesca
    Gmachl, Michael
    Alpar, Donat
    Lieb, Simone
    Jeschko, Astrid
    Mitsudomi, Tetsuya
    Kraut, Norbert
    Petronczki, Mark P.
    CANCER RESEARCH, 2022, 82 (12)
  • [43] The KRASG12C Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy
    Briere, David M.
    Li, Shuai
    Calinisan, Andrew
    Sudhakar, Niranjan
    Aranda, Ruth
    Hargis, Lauren
    Peng, David H.
    Deng, Jiehui
    Engstrom, Lars D.
    Hallin, Jill
    Gatto, Sole
    Fernandez-Banet, Julio
    Pavlicek, Adam
    Wong, Kwok-Kin
    Christensen, James G.
    Olson, Peter
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (06) : 975 - 985
  • [44] Discovery of AMG 510, a first-in-human covalent inhibitor of KRASG12C for the treatment of solid tumors
    Lanman, Brian A.
    Chen, Jian Jeffrey
    Liu, Longbin
    Lopez, Patricia
    Pickrell, Alexander J.
    Reed, Anthony B.
    Wang, Hui-Ling
    Achanta, Pragathi
    Canon, Jude
    Erlanson, Daniel A.
    Fucini, Raymond V.
    Jeong, Joon Won
    Mohr, Christopher
    Saiki, Anne Y.
    Cee, Victor J.
    Lipford, J. Russell
    Rex, Karen
    Volak, Laurie P.
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Nuclear Transport Protein XPO1 Inhibitor Enhances the Antitumor Activity of KRASG12C Inhibitors
    Khan, H. Y.
    Al-Hallak, M. N.
    Nagasaka, M.
    Uddin, M.
    Aboukameel, A.
    Kim, S.
    Beydoun, R.
    Mohammad, R.
    Philip, P. A.
    Azmi, A. S.
    PANCREAS, 2021, 50 (07) : 1070 - 1070
  • [46] Natural distribution of genomic alterations correlated with the resistance to KRASG12C inhibitor in Chinese colorectal cancer.
    He, Ke
    Chen, Yuerong
    Liu, Fei
    Li, Liheng
    Wu, Chaosheng
    Lv, Xiu
    Liu, Xinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15550 - E15550
  • [47] PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
    Chien-Hui Chan
    Li-Wen Chiou
    Tsai-Yu Lee
    Yun-Ru Liu
    Tsung-Han Hsieh
    Ching-Yao Yang
    Yung-Ming Jeng
    British Journal of Cancer, 2023, 128 : 148 - 159
  • [48] The distribution of genetic mutations correlated with resistance to KRASG12C inhibitors in Chinese patients with lung cancer.
    Lin, Shengcheng
    Ma, Kai
    Xu, Yafei
    Liu, Xinyi
    Huang, Xiaochun
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
    Chan, Chien-Hui
    Chiou, Li-Wen
    Lee, Tsai-Yu
    Liu, Yun-Ru
    Hsieh, Tsung-Han
    Yang, Ching-Yao
    Jeng, Yung-Ming
    BRITISH JOURNAL OF CANCER, 2023, 128 (01) : 148 - 159
  • [50] same name, Different Game: EGFR Drives Intrinsic KRASG12C Inhibitor Resistance in Colorectal Cancer
    Koleilat, Mohamad Karim
    Kwong, Lawrence N.
    CANCER DISCOVERY, 2020, 10 (08) : 1094 - 1096
12345